MedPath

Epilepsy nurse trial for adults with intellectual disabilities

Not Applicable
Completed
Conditions
Epilepsy and intellectual disability
Nervous System Diseases
Epilepsy
Registration Number
ISRCTN96895428
Lead Sponsor
niversity of Cambridge and Cambridgeshire and Peterborough NHS Foundation Trust (UK)
Brief Summary

2016 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/27342377 2018 results in: http://www.ncbi.nlm.nih.gov/pubmed/29457585

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
408
Inclusion Criteria

1. Age 18 - 65 years
2. The presence of a developmental intellectual disability with IQ of 70 or less
3. A diagnosis of epilepsy with a history of at least one seizure in the 6 months preceding recruitment into the study (not considered by those managing the epilepsy to have been a non-epileptic seizure)

Exclusion Criteria

1. The presence of a rapidly progressive physical or neurological illness
2. Alcohol or drug dependence

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The seizure severity scale from the Epilepsy in Learning Disabilities Quality of Life (ELDQOL-SSS) instrument. This is completed by carers and provides a detailed measure of the physical severity of seizures experienced in the preceding 4 weeks, including any associated injuries and the level of distress manifest by the patient after a seizure. This will be collected after 6 months in the trial.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath